Compare ARDX & VZLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ARDX | VZLA |
|---|---|---|
| Founded | 2007 | 2017 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.6B |
| IPO Year | 2014 | N/A |
| Metric | ARDX | VZLA |
|---|---|---|
| Price | $5.78 | $5.89 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 2 |
| Target Price | ★ $10.65 | $7.00 |
| AVG Volume (30 Days) | 2.7M | ★ 6.1M |
| Earning Date | 10-30-2025 | 12-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $398,234,000.00 | N/A |
| Revenue This Year | $22.77 | N/A |
| Revenue Next Year | $28.02 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 58.12 | N/A |
| 52 Week Low | $3.21 | $1.67 |
| 52 Week High | $6.78 | $5.95 |
| Indicator | ARDX | VZLA |
|---|---|---|
| Relative Strength Index (RSI) | 48.64 | 71.29 |
| Support Level | $5.63 | $5.55 |
| Resistance Level | $6.04 | $5.95 |
| Average True Range (ATR) | 0.24 | 0.30 |
| MACD | -0.02 | 0.05 |
| Stochastic Oscillator | 17.31 | 92.27 |
Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. It product Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.
Vizsla Silver Corp is a junior mineral exploration and development company focused on advancing its Panuco silver-gold project located in Sinaloa, Mexico. The property contains quartz-carbonate veins with workings defining both steeply plunging and sub-horizontal ore shoots. Mineralization occurs as silver sulphides including argentite and acanthite, native gold, electrum and native silver associated with pyrite, minor galena, sphalerite and rare chalcopyrite. It has one operating segment, which is principally mineral exploration.